Search Results - "Thosani, Sonali"

Refine Results
  1. 1

    Treatment for Malignant Pheochromocytomas and Paragangliomas: 5 Years of Progress by Jimenez, Paola, Tatsui, Claudio, Jessop, Aaron, Thosani, Sonali, Jimenez, Camilo

    Published in Current oncology reports (01-12-2017)
    “…Purpose of Review The purpose of this manuscript is to review the progress in the field of therapeutics for malignant pheochromocytomas and sympathetic…”
    Get full text
    Journal Article
  2. 2

    Reduced Risk of Colorectal Cancer With Use of Oral Bisphosphonates: A Systematic Review and Meta-Analysis by THOSANI, Nirav, THOSANI, Sonali N, KUMAR, Sheetanshu, NUGENT, Zoann, JIMENEZ, Camilo, SINGH, Harminder, GUHA, Sushovan

    Published in Journal of clinical oncology (10-02-2013)
    “…The association between oral bisphosphonate (BP) intake and colorectal cancer (CRC) risk has been investigated in several recent studies with conflicting…”
    Get full text
    Journal Article
  3. 3

    Role of EUS-FNA-Based Cytology in the Diagnosis of Mucinous Pancreatic Cystic Lesions: A Systematic Review and Meta-Analysis by Thosani, Nirav, Thosani, Sonali, Qiao, Wei, Fleming, Jason B, Bhutani, Manoop S, Guha, Sushovan

    Published in Digestive diseases and sciences (01-10-2010)
    “…Background Preoperative diagnosis of malignancy in pancreatic cystic lesions (PCLs) remains challenging. Most non-mucinous cystic lesions (NMCLs) are benign,…”
    Get full text
    Journal Article
  4. 4

    The Characterization of Pheochromocytoma and Its Impact on Overall Survival in Multiple Endocrine Neoplasia Type 2 by Thosani, Sonali, Ayala-Ramirez, Montserrat, Palmer, Lynn, Hu, Mimi I, Rich, Thereasa, Gagel, Robert F, Cote, Gilbert, Waguespack, Steven G, Habra, Mouhammed Amir, Jimenez, Camilo

    “…Context: Pheochromocytoma (PHEO) occurs in 50% of patients with multiple endocrine neoplasia type 2 (MEN2). It is unknown if the presence of PHEO is associated…”
    Get full text
    Journal Article
  5. 5

    Safe and effective dosing of basal-bolus insulin in patients receiving high-dose steroids for hyper-cyclophosphamide, doxorubicin, vincristine, and dexamethasone chemotherapy by Brady, Veronica, Thosani, Sonali, Zhou, Shouhou, Bassett, Roland, Busaidy, Naifa Lamki, Lavis, Victor

    Published in Diabetes technology & therapeutics (01-12-2014)
    “…Hyperglycemia occurs in cancer patients receiving high-dose steroids with cyclophosphamide, doxorubicin, vincristine, and dexamethasone (hyper-CVAD) protocol…”
    Get more information
    Journal Article
  6. 6
  7. 7

    A CASE OF ACQUIRED GENERALIZED LIPODYSTROPHY ASSOCIATED WITH PEMBROLIZUMAB IN A PATIENT WITH METASTATIC MALIGNANT MELANOMA by Bedrose, Sara, Turin, Christie G, Lavis, Victor R, Kim, Sang T, Thosani, Sonali N

    Published in AACE clinical case reports (01-01-2020)
    “…To describe an unusual immune-related adverse event (irAE), acquired generalized lipodystrophy (AGL), from checkpoint inhibitor therapy in a patient treated…”
    Get full text
    Journal Article
  8. 8

    Lung cancer-induced paraneoplastic syndromes by Yeung, Sai-Ching J, Habra, Mouhammed A, Thosani, Sonali N

    Published in Current opinion in pulmonary medicine (01-07-2011)
    “…PURPOSE OF REVIEWParaneoplastic syndromes occur commonly in patients with lung cancer, especially cancers of neuroendocrine origin. The syndromes can be the…”
    Get full text
    Journal Article
  9. 9

    Identifying Trends in Glycemic Management in the Acute Cancer Care Center at MD Anderson Cancer Center by Kikani, Nupur, Thosani, Sonali

    Published in The Journal of emergency medicine (01-01-2024)
    “…Hyperglycemia in the inpatient setting contributes to morbidity and mortality. Glycemic management in the emergency room setting is the initial gateway for…”
    Get full text
    Journal Article
  10. 10
  11. 11

    THU290 Identifying Trends In Glycemic Management In A Comprehensive Cancer Center by Kikani, Nupur, Thosani, Sonali

    Published in Journal of the Endocrine Society (05-10-2023)
    “…Abstract Disclosure: N. Kikani: None. S. Thosani: None. Hyperglycemia in the inpatient setting contributes to morbidity and mortality. Glycemic management in…”
    Get full text
    Journal Article
  12. 12

    Euglycemic DKA as an Initial Presentation of Immunotherapy-Induced Insulin-Dependent Diabetes by IYER, PRIYANKA, THOSANI, SONALI N.

    Published in Diabetes (New York, N.Y.) (01-07-2018)
    “…New onset insulin dependent diabetes (DM) has been reported in cancer patients (pts) receiving immunotherapy (IO). Typically, pts have Grade 3 hyperglycemia…”
    Get full text
    Journal Article
  13. 13

    THU325 Covid-19 Outcomes In Cancer Patients With Diabetes by Tan Ngo, Emmeline Monique, Thosani, Sonali

    Published in Journal of the Endocrine Society (05-10-2023)
    “…Abstract Disclosure: E.T. Ngo: None. S. Thosani: None. Diabetes mellitus and cancer are risk factors for poor outcomes in patients with Covid-19 (Covid). In…”
    Get full text
    Journal Article
  14. 14

    Denosumab: a new agent in the management of hypercalcemia of malignancy by Thosani, Sonali, Hu, Mimi I

    Published in Future oncology (London, England) (01-11-2015)
    “…Hypercalcemia of malignancy is an oncologic emergency due to tumoral factors that stimulate osteoclast-mediated bone resorption. It requires a combination of…”
    Get full text
    Journal Article
  15. 15

    Pancreatic volumes in immune checkpoint inhibitor-induced diabetes by Jeun, Rebecca, Yedururi, Sireesha, Lavis, Victor, Best, Conor, Varghese, Jeena, Dadu, Ramona, Glitza, Isabella Claudia, Thosani, Sonali

    Published in Journal of clinical oncology (20-05-2021)
    “…Abstract only 2644 Background: Immune checkpoint inhibitor-mediated insulin dependent diabetes (ICI-DM) is a rare and irreversible adverse event often…”
    Get full text
    Journal Article
  16. 16

    Constipation: an overlooked, unmanaged symptom of patients with pheochromocytoma and sympathetic paraganglioma by Thosani, Sonali, Ayala-Ramirez, Montserrat, Román-González, Alejandro, Zhou, Shouhao, Thosani, Nirav, Bisanz, Annette, Jimenez, Camilo

    Published in European journal of endocrinology (01-09-2015)
    “…ObjectivePheochromocytomas (PHs) and sympathetic paragangliomas (PGs) are tumors that produce catecholamines, predisposing patients to cardiovascular disease…”
    Get full text
    Journal Article
  17. 17

    Diabetic Ketoacidosis With Alpelisib by Jeun, Rebecca, Lavis, Victor Ralph, Thosani, Sonali

    Published in Journal of the Endocrine Society (03-05-2021)
    “…Abstract Background: Hyperglycemia is a frequently reported adverse effect of alpelisib, an isoform specific phosphoinositide 3 kinase inhibitor, which is…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Detection and Management of Perioperative Hyperglycemia at a Tertiary Cancer Center by Taylor, Jolyn S., Fellman, Bryan M., Raty, Sally, Lasala, Javier, Iniesta, Maria D., Cain, Katherine E., Horner, Allison A., Bruno, Morgan, Folloder, Justin P., Knippel, Susan L., Khanh, Vu, Popovich, Shannon, Katz, Matthew H. G., Best, Conor, Thosani, Sonali

    Published in Annals of surgical oncology (01-05-2024)
    “…Introduction To improve the detection and management of perioperative hyperglycemia at our tertiary cancer center, we implemented a glycemic control quality…”
    Get full text
    Journal Article
  20. 20

    FRI685 Denosumab Withdrawal Is Associated With Hypercalcemia In Adults With Osteoporosis And Bone Metastases by Patil, Madhuri D, Thosani, Sonali, Bassett, Roland L, Wang, Zhongya, Guise, Theresa A

    Published in Journal of the Endocrine Society (05-10-2023)
    “…Abstract Disclosure: M.D. Patil: None. S. Thosani: None. R.L. Bassett Jr: None. Z. Wang: None. T.A. Guise: None. Denosumab (dmab) is useful to treat conditions…”
    Get full text
    Journal Article